Skip to content

Comparison of skin swelling and clinical results between two numbing techniques in minor skin procedures.

Tissue distortion and clinical outcomes in field block versus infiltrative anaesthesia for small cutaneous excisions: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103694
Enrollment
222
Registered
2026-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissue

Interventions

Intervention1: Field block anaesthesia: Subdermal circumferential anesthesia given approximately 10 mm outside the planned elliptical excision, using 2 percentage lignocaine with adrenaline (1:200000)

Sponsors

Jawaharlal Institute of Postgraduate Medical Education and Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults aged more than or equal to 18 years who provide written informed consent. 2.Patients with benign or suspected benign cutaneous lesions on the trunk or extremities. 3.Lesion size 0.5 to 2.5 cm in longest pre injection diameter. 4.Planned simple elliptical excision with primary closure under local anesthesia

Exclusion criteria

Exclusion criteria: 1.Lesions on face, scalp, periungual area, genitals, or perineum (where named nerve block is standard). 2.Local infection, cellulitis, or edema at the operative site. 3. Known allergy or contraindication to lignocaine or adrenaline (e.g., arrhythmia, hyperthyroidism, pheochromocytoma). 4.Coagulopathy or anticoagulant therapy unsuitable for skin surgery. 5.Recurrent lesions or prior surgery at the same site. 6.Complex reconstruction planned (flap, graft, or secondary intention healing). 7.Inability to cooperate or comply with anesthesia testing or follow-up. Lesion Selection (for patients with multiple eligible lesions) If a participant has more than one eligible lesion, only one will be enrolled to maintain independence of observations. Selection will follow this hierarchy: 1.The most superior (cephalad) lesion is chosen. 2.If two lesions lie at the same vertical level, the left-sided lesion is chosen. 3.For midline pairs at the same level, the more proximal (closer to the trunk) lesion is selected. Selection will be finalized before randomization and recorded in the screening log; no substitution will be allowed if the selected lesion later becomes ineligible.

Design outcomes

Primary

MeasureTime frame
Composite Distortion Index (CDI) at 120 seconds following anaesthetic injection- expressed as percentage change in ellipse geometryTimepoint: intraoperative 120 seconds after anaesthetic injection

Secondary

MeasureTime frame
1.CDI at 60 seconds. 2.CDI at 180 seconds. 3.Injection pain NRS (0-10). 4.Rescue anaesthesia requirement(Y/N) and rescue volume (mL). 5.Time to onset of anaesthesia (seconds). 6.Complications at 7-10 days (haematoma, infection, dehiscence). 7.Surgeon ease-of-technique or workflow using Likert scale (1-5). 8.Cosmetic outcome at 8 weeks assessed by POSAS or VAS 9.Patient satisfaction at 8 weeks assessed by Likert scale(1-5) Timepoint: intraoperative, 1 week after procedure, 8 weeks after procedure

Countries

India

Contacts

Public ContactDr Sheetanshu Kumar

Jawaharlal Institute of Postgraduate Medical Education and Research

kumar.sheetanshu@gmail.com6280345925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026